Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06101030
Other study ID # InSee 202301
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 16, 2024
Est. completion date July 7, 2024

Study information

Verified date March 2024
Source Tidal Medical Technologies
Contact Michael Martin, RN
Phone 18582121728
Email michael@tidalmed.tech
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This study is designed to determine if patients using an incentive spirometer with visual and auditory signals will increase their use of the incentive spirometer and prevent lung complications.


Description:

The purpose of this study is to determine if the frequency of patients' use of physician ordered incentive spirometry increases with visual and auditory electronic encouragement (signals) compared to the no signal cohort. Secondarily this study will correlate short term outcomes of study patients to known short term outcome data from the study site and published data to determine if there is a relationship between frequency of use and positive or outcomes or complications, as cited by peer reviewed literature.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date July 7, 2024
Est. primary completion date June 3, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients must meet all the following Inclusion criteria to be eligible for participation in the study: - Patient has undergone a qualifying surgical procedure. - Patient is aged 18 years or over. - Patient has incentive spirometry ordered or incentive spirometry must be part of the study site's standard of care which is implemented by hospital staff. - Patient is able to comply with all study required incentive spirometry instructions. - Patient is without severe hearing or impaired visual acuity deficiency such that they cannot hear or see the audible and visual signal for the InSee monitor. Exclusion Criteria: - Patients meeting any of the following exclusion criteria at baseline will be excluded from study participation: - Vulnerable Populations (Pregnant, minors, prisoners, those with significantly reduced mental acuity). - Patients where incentive spirometry is inappropriate (patients with Tractotomy, patients who are hemodynamically unstable, patients in reverse isolation due to infection). - Patients with a history of prior non-compliance or the presence or history of psychiatric condition (including drug or alcohol addiction), or cognitive issue which would in the opinion of the investigator, make it difficult for the patient to comply with the study procedures or follow the investigators instructions. - Any medical condition that, in the opinion of the investigator, would place the patient at increased risk if they participated. - Any Physician determination that the patient should not participate.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Signal On
InSee monitor patient signals are on.

Locations

Country Name City State
United States Tidal Study Site Galveston Texas
United States Tidal Study Site New Brunswick New Jersey
United States Tidal Study Site Rochester Minnesota
United States Tidal Reseach Site Silver Spring Maryland

Sponsors (1)

Lead Sponsor Collaborator
Tidal Medical Technologies

Country where clinical trial is conducted

United States, 

References & Publications (3)

Alwekhyan SA, Alshraideh JA, Yousef KM, Hayajneh F. Nurse-guided incentive spirometry use and postoperative pulmonary complications among cardiac surgery patients: A randomized controlled trial. Int J Nurs Pract. 2022 Apr;28(2):e13023. doi: 10.1111/ijn.13023. Epub 2021 Oct 22. — View Citation

Eltorai AEM, Baird GL, Eltorai AS, Pangborn J, Antoci V Jr, Cullen HA, Paquette K, Connors K, Barbaria J, Smeals KJ, Agarwal S, Healey TT, Ventetuolo CE, Sellke FW, Daniels AH. Incentive Spirometry Adherence: A National Survey of Provider Perspectives. Respir Care. 2018 May;63(5):532-537. doi: 10.4187/respcare.05882. Epub 2018 Jan 23. — View Citation

Sweity EM, Alkaissi AA, Othman W, Salahat A. Preoperative incentive spirometry for preventing postoperative pulmonary complications in patients undergoing coronary artery bypass graft surgery: a prospective, randomized controlled trial. J Cardiothorac Surg. 2021 Aug 24;16(1):241. doi: 10.1186/s13019-021-01628-2. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Intubation due to a respiratory diagnosis Postoperative Intubation due to a respiratory diagnosis during hospitalization throughout hospitalization an average of 5 days
Other Reintubation due to a respiratory diagnosis Reintubation due to a respiratory diagnosis during hospitalization throughout hospitalization an average of 5 days
Other ICU length of stay Postoperative length of stay in ICU throughout hospitalization an average of 5 days
Other Inpatient hospital length of stay Postoperative length of stay in hospital throughout hospitalization an average of 5 days
Other Change in SP02 Postoperative Change in SP02 throughout hospitalization an average of 5 days
Primary Number of successful inspiratory breaths attempts per day. successful inspiratory breaths is defined as achieving the goal tidal volume through hospitalization an average of 5 days
Primary Total number of inspiratory breaths achieved per day. Inspiratory breaths while using the incentive spirometer throughout hospitalization an average of 5 days
Secondary Time to achieve goal tidal volume. Time in to achieve prescribed goal inspiratory tidal volume. throughout hospitalization an average of 5 days
Secondary Post operative length of O2 use. Length of time from surgery until 02 is discontinued. throughout hospitalization an average of 5 days
Secondary Change in 02 flow rate. Change in 02 flow rate delivered to the patient. throughout hospitalization an average of 5 days
Secondary inpatient Pulmonary complication rates. Pulmonary complications during hospitalization throughout hospitalization an average of 5 days
Secondary Hospital discharge on O2. If a study patient is discharged on 02. throughout hospitalization an average of 5 days
Secondary Changes in Inspiratory volume. Changes (- or +) in the inspiratory volume a patient is able to achieve. throughout hospitalization an average of 5 days
Secondary Change in Inspiratory volume. Postoperative change in inspiratory volume throughout hospitalization an average of 5 days
Secondary Readmission for pulmonary complication Readmission for pulmonary complication up to 30 days after hospital discharge 30 days after discharge
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02881385 - Effects on Respiratory Patterns and Patient-ventilator Synchrony Using Pressure Support Ventilation N/A
Recruiting NCT03157245 - Incidence of Deep Vein Thrombosis on Central Venous Catheters in the Post Operative Period of Carcinologic Surgery N/A
Not yet recruiting NCT06060366 - Impact of Pulmonary Endarterectomy on Sleep-Related Breathing Disorders in CTEPH: The IPES Trial